一种基因型第一的方法来定义复杂疾病的亚型
Holly A Stessman1, Raphael Bernier2, Evan E Eichler3
1Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Cell
|March 4, 2014
概括
在医学遗传学中,一种新的"基因型优先"策略可以识别导致疾病的基因和自闭症等复杂疾病的表型. 这种方法承诺通过首先分析遗传变异来提供有针对性的疗法.
科学领域:
- 医学遗传学 医学遗传学
- 基因组学就是基因组学.
- 复杂疾病研究 复杂疾病研究
背景情况:
- 传统的医学遗传学将患者的表型与基因型联系起来.
- 像自闭症这样的复杂疾病对基因型-表型相关性提出了挑战.
- 遗传变异发现的进步使新的研究策略成为可能.
研究的目的:
- 为复杂疾病提出和探索"基因型优先"的方法.
- 研究基因变异分析中反向策略的潜力.
- 确定复杂遗传疾病的基因型-表型相关性.
主要方法:
- 系统地发现与复杂疾病相关的遗传变异.
- 发展研究人员,临床医生和患者家属的综合网络.
- 利用从基因型到表型的反向策略.
主要成果:
- 由于遗传发现的进展,提出的基因型第一方法正在变得可行.
- 这一策略有助于将致病效应赋予各种基因.
- 它有助于从特定的基因型中识别出临床上可识别的表型.
结论:
- 一种基因型第一方法为像自闭症这样的复杂疾病提供了一个有希望的替代方案.
- 这一战略需要合作网络才能成功实施.
- 它有可能为患者子集开发有针对性的,改进的治疗方法.
相关概念视频
Genome-wide Association Studies-GWAS
12.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.6K
Genetic Lingo
84.7K
Overview
84.7K
Incomplete Dominance
19.0K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
19.0K
Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Pedigree Analysis
78.8K
Overview
78.8K
Principles of Pharmacogenetics: Types of Genetic Variants
138
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
138


